The median concentration of IL-10 in plasma showed a clear decreasing trend from healthy controls to NASH, as well as from hepatitis without significant fibrosis to liver cirrhosis. This evidence concerns the gene IL10 and metabolic dysfunction-associated steatohepatitis.